| |
Active Ingredients / Generics:
propafenone hydrochloride
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and Lactation
- Change to section 4.8 - Undesirable Effects
- Change to section 4.9 - Overdose
|
Active Ingredients / Generics:
budesonide
- Change to section 4.4 - Special warnings and precautions for Use
|
Active Ingredients / Generics:
bumetanide
- Change to section 6. 3 - Shelf Life
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
bumetanide
- Change to section 6. 3 - Shelf Life
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
citalopram hydrochloride
- Change to warnings or special precautions for use
- Change of contra-indications
- Change to side-effects
- Change to drug interactions
- Change to dosage and administration
|
Active Ingredients / Generics:
citalopram hydrochloride
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable Effects
- Change to section 4.9 - Overdose
- Change to section 5.1 - Pharmacodynamic Properties
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
citalopram hydrobromide
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable Effects
- Change to section 4.9 - Overdose
- Change to section 5.1 - Pharmacodynamic Properties
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
citalopram hydrobromide
- Change to warnings or special precautions for use
- Change of contra-indications
- Change to side-effects
- Change to drug interactions
- Change to dosage and administration
|
Active Ingredients / Generics:
pancreatin
|
Active Ingredients / Generics:
pancreatin
|
Active Ingredients / Generics:
pancreatin
|
Active Ingredients / Generics:
pancreatin
|
Active Ingredients / Generics:
hepatitis b vaccine (rDNA)
- Change to date of revision
- Change to warnings or special precautions for use
|
Active Ingredients / Generics:
econazole nitrate
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.9 - Overdose
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
econazole nitrate
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.9 - Overdose
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
econazole nitrate
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.9 - Overdose
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
latanoprost
|
Active Ingredients / Generics:
timolol maleate, latanoprost
|
Active Ingredients / Generics:
methylprednisolone sodium succinate
|
Active Ingredients / Generics:
methylprednisolone sodium succinate
|
Active Ingredients / Generics:
sertraline hydrochloride
- Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
|
Active Ingredients / Generics:
ustekinumab
- Change of contra-indications
- Change to side-effects
|
Active Ingredients / Generics:
ustekinumab
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.6 - Pregnancy and Lactation
- Change to section 4.8 - Undesirable Effects
- Change to section 5.1 - Pharmacodynamic Properties
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
sunitinib malate
- Correction of spelling/typing errors
|
Active Ingredients / Generics:
tick borne encephalitis virus
- Change to section 6. 3 - Shelf Life
|
Active Ingredients / Generics:
lidocaine
- Change to how the medicine works
- Change to date of revision
|
Active Ingredients / Generics:
lidocaine hydrochloride, adrenaline tartrate
- Improved Electronic Presentation
|
Active Ingredients / Generics:
levocetirizine dihydrochloride
- Change to section 4.1 - Therapeutic indications
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 5.1 - Pharmacodynamic Properties
- Change to section 5.2 - Pharmacokinetic Properties
|
Active Ingredients / Generics:
ondansetron hydrochloride dihydrate
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.8 - Undesirable Effects
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
ondansetron
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.8 - Undesirable Effects
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
ondansetron
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.8 - Undesirable Effects
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
ondansetron
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.8 - Undesirable Effects
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
ondansetron hydrochloride dihydrate
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.8 - Undesirable Effects
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
ondansetron hydrochloride dihydrate
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.8 - Undesirable Effects
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
ondansetron hydrochloride dihydrate
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.8 - Undesirable Effects
- Change to section 10 date of revision of the text
|
| |
Active Ingredients / Generics:
spironolactone, hydroflumethiazide
- Change to Marketing Authorisation Holder
|
Amaryl
Active Ingredients / Generics:
glimepiride
- PIL Product / presentation discontinued
|
Amaryl
Active Ingredients / Generics:
glimepiride
- SPC Product / presentation discontinued
|
Apidra 100 U/ml solution for injection in OptiClik cartridge
Active Ingredients / Generics:
insulin glulisine
- PIL Product / presentation discontinued
|
Apidra 100 Units/ml solution for injection in a cartridge for OptiClik
Active Ingredients / Generics:
insulin glulisine
- SPC Product / presentation discontinued
|
Active Ingredients / Generics:
oxymetazoline hydrochloride
- Change to section 4.2 - Posology and method of administration
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.8 - Undesirable Effects
- Change to section 4.9 - Overdose
|
Active Ingredients / Generics:
levobupivacaine hydrochloride
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.8 - Undesirable Effects
- Change to section 5.1 - Pharmacodynamic Properties
- Change to section 6. 5 - Nature and Contents of Container
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
colistin sulphate
- Change to section 4.2 - Posology and method of administration
|
Active Ingredients / Generics:
metformin hydrochloride, pioglitazone hydrochloride
- Correction of spelling/typing errors
|
Cordarone X 100, Cordarone X 200
Active Ingredients / Generics:
amiodarone hydrochloride
- PIL Product / presentation discontinued
|
Cordarone X 100, Cordarone X 200
Active Ingredients / Generics:
amiodarone hydrochloride
- SPC Product / presentation discontinued
|
Active Ingredients / Generics:
liquid paraffin, benzalkonium chloride, isopropyl myristate, chlorhexidine dihydrochloride
- Change to Further Information section
- Change to date of revision
|
Active Ingredients / Generics:
liquid paraffin, benzalkonium chloride, isopropyl myristate, chlorhexidine dihydrochloride
- Change to Further Information section
- Change to date of revision
|
Dicynene
Active Ingredients / Generics:
etamsylate
|
Dicynene 500 Tablets
Active Ingredients / Generics:
etamsylate
|
Active Ingredients / Generics:
fluconazole
- New individual SPC (was previously included in combined SPC)
|
Active Ingredients / Generics:
fluconazole
- New individual SPC (was previously included in combined SPC)
|
Active Ingredients / Generics:
fluconazole
- New individual SPC (was previously included in combined SPC)
|
Active Ingredients / Generics:
propofol
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.6 - Pregnancy and Lactation
- Change to section 4.7 - Effects on Ability to Drive and Use Machines
- Change to section 4.8 - Undesirable Effects
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
propofol
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.6 - Pregnancy and Lactation
- Change to section 4.7 - Effects on Ability to Drive and Use Machines
- Change to section 4.8 - Undesirable Effects
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
liquid paraffin
- Change to Further Information section
- Change to date of revision
|
Active Ingredients / Generics:
liquid paraffin, isopropyl myristate
- Change to Further Information section
- Change to date of revision
|
Eloxatin 5 mg/ml concentrate for solution for infusion
Active Ingredients / Generics:
oxaliplatin
- PIL Product / presentation discontinued
|
Eloxatin 5 mg/ml concentrate for solution for infusion
Active Ingredients / Generics:
oxaliplatin
- SPC Product / presentation discontinued
|
Active Ingredients / Generics:
acarbose
- Change to date of revision
|
Active Ingredients / Generics:
acarbose
- Change to date of revision
|
Active Ingredients / Generics:
adalimumab
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.6 - Pregnancy and Lactation
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
poliomyelitis vaccine, diphtheria, tetanus and pertussis vaccine
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 10 date of revision of the text
|
Insuman Basal Optiset
Active Ingredients / Generics:
human insulin
- PIL Product / presentation discontinued
|
Active Ingredients / Generics:
midazolam hydrochloride
- Addition of joint PIL covering all presentations
|
Active Ingredients / Generics:
midazolam hydrochloride
- Addition of joint PIL covering all presentations
|
Active Ingredients / Generics:
midazolam hydrochloride
- Individual presentations superseded by joint PIL
|
Active Ingredients / Generics:
pegfilgrastim
- Change due to user-testing of patient information
|
Active Ingredients / Generics:
ritonavir
- Change to date of revision
- Change to side-effects
|
Active Ingredients / Generics:
ritonavir
- Change to date of revision
- Change to side-effects
|
Active Ingredients / Generics:
xylometazoline hydrochloride
|
Active Ingredients / Generics:
guaifenesin, pseudoephedrine hydrochloride
- Change to section 4.9 - Overdose
|
Active Ingredients / Generics:
sodium fusidate
- Change to Further Information section
- Change to date of revision
- Change to warnings or special precautions for use
- Change of contra-indications
- Change to side-effects
- Change to drug interactions
- Change to name of manufacturer
|
Active Ingredients / Generics:
nilotinib hydrochloride monohydrate
- Change to Further Information section
|
Active Ingredients / Generics:
nilotinib hydrochloride monohydrate
- Change to Further Information section
|
Active Ingredients / Generics:
tramadol hydrochloride
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.6 - Pregnancy and Lactation
- Change to section 4.7 - Effects on Ability to Drive and Use Machines
- Change to section 4.8 - Undesirable Effects
- Change to section 4.9 - Overdose
- Change to section 5.1 - Pharmacodynamic Properties
- Change to section 5.2 - Pharmacokinetic Properties
- Change to section 5.3 - Preclinical Safety Data
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
typhoid vaccine
- Change to date of revision
- Change to warnings or special precautions for use
|
Active Ingredients / Generics:
diclofenac sodium
|
Active Ingredients / Generics:
tramadol hydrochloride
- Change to section 6. 4 - Special Precautions for Storage
|
| |
Active Ingredients / Generics:
acwy meningococcal polysaccharide
- Change to date of revision
- Change to warnings or special precautions for use
|
Active Ingredients / Generics:
acwy meningococcal polysaccharide
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
amikacin sulfate
- Change/addition of instructions for reconstitution and/ or administration
- Change to warnings or special precautions for use
- Change to side-effects
- Change to information about pregnancy or lactation
|
Active Ingredients / Generics:
ofatumumab
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.6 - Pregnancy and Lactation
- Change to section 4.8 - Undesirable Effects
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
levobupivacaine hydrochloride
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.8 - Undesirable Effects
- Change to section 5.1 - Pharmacodynamic Properties
- Change to section 6. 5 - Nature and Contents of Container
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
levobupivacaine hydrochloride
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.8 - Undesirable Effects
- Change to section 5.1 - Pharmacodynamic Properties
- Change to section 6. 5 - Nature and Contents of Container
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
levobupivacaine hydrochloride
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.8 - Undesirable Effects
- Change to section 5.1 - Pharmacodynamic Properties
- Change to section 6. 5 - Nature and Contents of Container
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
beclometasone dipropionate
- Change to Further Information section
- Change to date of revision
|
Active Ingredients / Generics:
colistin sulphate
- Addition of separate PILs covering individual presentations
- Change to dosage and administration
|
Active Ingredients / Generics:
medroxyprogesterone acetate
- Change to date of revision
- Change to Marketing Authorisation Holder
|
Active Ingredients / Generics:
medroxyprogesterone acetate
- Change to section 7 - Marketing Authorisation Holder
- Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
fluconazole
- Improved Electronic Presentation
|
Active Ingredients / Generics:
fluconazole
- Correction of spelling/typing errors
|
Active Ingredients / Generics:
fluconazole
- Correction of spelling/typing errors
|
Active Ingredients / Generics:
fluconazole
- Correction of spelling/typing errors
|
Active Ingredients / Generics:
fluconazole
- Correction of spelling/typing errors
|
Active Ingredients / Generics:
propofol
- Change to date of revision
- Change to side-effects
|
Active Ingredients / Generics:
propofol
- Change to date of revision
- Change to side-effects
|
Doxorubicin Hydrochloride 2 mg/ml solution for infusion (hameln)
Active Ingredients / Generics:
doxorubicin hydrochloride
- PIL Product / presentation discontinued
|
Active Ingredients / Generics:
fentanyl
- Change to section 4.2 - Posology and method of administration
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
hepatitis b vaccine (rDNA)
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
hepatitis b vaccine (rDNA)
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
hepatitis b vaccine (rDNA)
- Change to date of revision
- Change to warnings or special precautions for use
|
Epirubicin hydrochloride 2mg/ml solution for injection or infusion (hameln)
Active Ingredients / Generics:
epirubicin hydrochloride
- PIL Product / presentation discontinued
|
Active Ingredients / Generics:
acarbose
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and Lactation
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
acarbose
- Change to section 4.3 - Contraindications
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
- Change to section 4.6 - Pregnancy and Lactation
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
hydrocortisone acetate
|
Active Ingredients / Generics:
hepatitis a vaccine, typhoid vaccine
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
hepatitis a vaccine, typhoid vaccine
- Change to date of revision
- Change to warnings or special precautions for use
|
Active Ingredients / Generics:
poliomyelitis vaccine, diphtheria, tetanus and pertussis vaccine
- Change to date of revision
- Change to warnings or special precautions for use
|
Active Ingredients / Generics:
rufinamide
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 9 - Date of first Authorisation/renewal of the Authorisation
- Change to section 10 date of revision of the text
|
Modrenal
Active Ingredients / Generics:
trilostane
|
Modrenal
Active Ingredients / Generics:
trilostane
|
Active Ingredients / Generics:
ondansetron hydrochloride dihydrate
- Change to dosage and administration
|
Active Ingredients / Generics:
tamsulosin hydrochloride
- Change to section 2 - Qualitative and quantitative composition
- Change to section 3 - Pharmaceutical form
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 6.1 - List of Excipients
|
Active Ingredients / Generics:
pantoprazole sodium sesquihydrate
- Change to section 4.8 - Undesirable Effects
|
Active Ingredients / Generics:
nilotinib hydrochloride monohydrate
- Change to section 6. 5 - Nature and Contents of Container
- Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
|
Active Ingredients / Generics:
nilotinib hydrochloride monohydrate
- Change to section 6. 5 - Nature and Contents of Container
- Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
|
Active Ingredients / Generics:
tramadol hydrochloride
- Change to date of revision
- Change to warnings or special precautions for use
- Change to side-effects
- Change to information about pregnancy or lactation
- Change to information about driving or using machinery
|
Active Ingredients / Generics:
trimethoprim
|
Active Ingredients / Generics:
typhoid vaccine
- Change to section 4.4 - Special warnings and precautions for Use
- Change to section 10 date of revision of the text
|
Active Ingredients / Generics:
denosumab
- Change to section 6. 5 - Nature and Contents of Container
|
Active Ingredients / Generics:
tramadol hydrochloride
- Change to storage instructions
|